The induction of EGF deprivation by active immunotherapy is an emerging concept developed by Cuban researchers, which includes the manipulation of the individual's immune response to generate neutralizing antibodies (Abs) against self-EGF that reduce the size of the tumor or prevent its progression 8, 9. This evidence concerns the gene EGF and neoplasm.